Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: A case report

Special Care in Dentistry

Volumn 29, Issue 5, 2009, Pages 215-217

  Sabuncuoglu, Osman ^a   Ekinci, Ozalp ^a   Berkem, Meral ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Adolescent; Buspirone; Fluoxetine; Sleep bruxism

Indexed keywords

BUSPIRONE; FLUOXETINE; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ARTICLE; BRUXISM; CASE REPORT; CHEMICALLY INDUCED DISORDER; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; POLYSOMNOGRAPHY;

ADOLESCENT; BUSPIRONE; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HUMANS; POLYSOMNOGRAPHY; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS; SLEEP BRUXISM;

EID: 70350334887     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.2009.00091.x     Document Type: Article

References (24)

1. American Academy of Sleep Medicine. The International Classification of Sleep Disorders. 2nd ed. Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine; 2005.
2. Bader G, Lavigne G. Sleep bruxism; an overview of an oromandibular sleep movement disorder. Sleep Med Rev 2000;4:27-43.
3. Widmalm SE, Christiansen RL, Gunn SM. Oral parafunctions as temporomandibular disorder risk factors in children. Cranio 1995;13:242-246.
4. Lavigne GJ, Kato T, Kolta A, Sessle BJ. Neurobiological mechanisms involved in sleep bruxism. Crit Rev Oral Biol Med 2003;14:30-46.
5. Lobbezoo F, Lavigne GJ, Tanguay R, Montplaisir JY. The effect of catecholamine precursor L-dopa on sleep bruxism: a controlled clinical trial. Mov Disord 1997;12:73-78.
6. Van der Zaag J, Lobbezoo F, Van der Avoort PG, et al. Effects of pergolide on severe sleep bruxism in a patient experiencing oral implant failure. J Oral Rehabil 2007;34:317-322.
7. Lobbezoo F, Soucy JP, Hartman NG, et al. Effects of the D2 receptor agonist bromocriptine on sleep bruxism: report of two single-patient clinical trials. J Dent Res 1997;76:1610-1614.
8. Lavigne GJ, Soucy JP, Lobbezoo F, et al. Double-blind, crossover, placebo-controlled trial of bromocriptine in patients with sleep bruxism. Clin Neuropharmacol 2001;24:145-149.
9. Ellison JM, Stanziani P. SSRI-associated nocturnal bruxism in four patients. J Clin Psychiatry 1993;54:432-434.
10. Bostwick JM, Jaffee MS. Buspirone as an antidote to SSRI-induced bruxism in 4 cases. J Clin Psychiatry 1999;60:857-860.
11. Lobbezoo F, van Denderen RJ, Verheij JG, Naeije M. Reports of SSRI-associated brux- ism in the family physician's office. J Orofac Pain 2001;15:340-346.
12. Romanelli F, Adler DA, Bungay KM. Possible paroxetine-induced bruxism. Ann Pharmacother 1996;30:1246-1248.
13. Ryan ND. Medication treatment for depression in children and adolescents. CNS Spectr 2003;8:283-287.
14. Emslie GJ, Mayes TL. Mood disorders in children and adolescents: psychopharmaco- logical treatment. Biol Psychiatry 2001;49:1082-1090.
15. Everett AV Pharmacologic treatment of adolescent depression. Curr Opin Pediatr 2002;14:213-218.
16. Leo RJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 1996;57:449-454.
17. Salazar DE, Frackiewicz EJ, Dockens R, et al. Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. J Clin Pharmacol 2001;41:1351-1358.
18. Edwards DJ, Chugani DC, Chugani HT, et al. Pharmacokinetics of buspirone in autistic children. J Clin Pharmacol 2006;46:508-514.
19. Carrey NJ, Wiggins DM, Milin RP. Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner. Drugs 1996;51:750-759.
20. Zwier KJ, Rao U. Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type). J Am Acad Child Adolesc Psychiatry 1994;33:1007-1011.
21. Hanna GL, Feibusch EL, and Albright KJ. Buspirone treatment of anxiety, associated with pharyngeal dysphagia in a four-year old. J Child Adolesc Psychopharmacol 1997;7:137-143.
22. Appelberg BG, Syvälahti EK, Koskinen TE, et al. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. J Clin Psychiatry 2001;62:448-452.
23. Joffe RT, Schuller DR. An open study of bus- pirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 1993;54:269-271.
24. Landén M, Eriksson E, Agren H, Fahlén T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol 1999;19:268-271.